Stage IV Bladder Urothelial Carcinoma
6 clinical trials · Condition
◉ Watch Stage IV Bladder Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors (NCT02717156) | University of Southern California | 2016-11-21 |
| Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery (NCT02944357) | Mayo Clinic | 2016-11-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer (NCT02718742) | Mayo Clinic | 2016-06-01 |
| Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer (NCT02494635) | University of Southern California | 2015-09-16 |
| Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer (NCT02437370) | University of California, Davis | 2015-09-01 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820) | Roswell Park Cancer Institute | 2012-03-01 |
Track Stage IV Bladder Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.